IL1B and cancer: Myriad studies have revealed that exposing stromal fibroblasts to cancer-targeted genotoxic agents resulted in significant upregulation of inflammatory factors or cytokines including interleukin (IL)-1β, matrix metalloproteinase-3, IL-6, WNT16B, and IL-813,20,26,29.